[PERSON]
JAMA Dermatology
Featured in 1 tracked story · first seen
Situations
[ACTIVE]
[HEALTH]
Upadacitinib clinical trials for alopecia areata
3 clusters · 12 sources · last updated
Latest: Upadacitinib shows significant hair regrowth in severe alopecia areata trials
Two phase 3 clinical trials, UP-AA1 and UP-AA2, have demonstrated that the JAK inhibitor upadacitinib (brand name Rinvoq) shows significant promise in treating severe alopecia areata. The studies, published in JAMA Derma